Syra Health Revenue 2022-2024 | SYRA
Syra Health revenue from 2022 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Syra Health Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $6 |
| 2022 | $6 |
| 2021 | $1 |
| Syra Health Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $2 |
| 2024-06-30 | $2 |
| 2024-03-31 | $2 |
| 2023-12-31 | $2 |
| 2023-09-30 | $2 |
| 2023-06-30 | $1 |
| 2023-03-31 | $1 |
| 2022-12-31 | |
| 2022-09-30 | $2 |
| 2021-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.004B | $0.006B |
| Syra Health Corp. is a healthcare technology company. It offers products and services in digital health, behavioral and mental health, population health management, health education and healthcare workforce. Syra Health Corp. is based in CARMEL, Ind. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.870B | 55.80 |
| Tempus AI (TEM) | United States | $9.036B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.145B | 207.11 |
| Inspire Medical Systems (INSP) | United States | $5.799B | 180.84 |
| IRhythm Technologies (IRTC) | United States | $3.407B | 0.00 |
| Privia Health (PRVA) | United States | $2.742B | 228.50 |
| Enovis (ENOV) | United States | $2.671B | 17.80 |
| Azenta (AZTA) | United States | $2.470B | 131.83 |
| Clover Health Investments (CLOV) | United States | $2.200B | 0.00 |
| Omnicell (OMCL) | United States | $2.084B | 68.17 |
| Schrodinger (SDGR) | United States | $1.827B | 0.00 |
| 10x Genomics (TXG) | United States | $1.816B | 0.00 |
| Phreesia (PHR) | United States | $1.654B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.850B | 0.00 |
| Standard BioTools (LAB) | United States | $0.577B | 0.00 |
| Talkspace (TALK) | United States | $0.524B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.509B | 0.00 |
| TruBridge (TBRG) | United States | $0.370B | 107.91 |
| Nyxoah SA (NYXH) | Belgium | $0.368B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.343B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.229B | 0.00 |
| Pulmonx (LUNG) | United States | $0.224B | 0.00 |
| American Well (AMWL) | United States | $0.165B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.090B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.087B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.056B | 0.00 |
| 111 (YI) | China | $0.050B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.047B | 0.00 |
| Outset Medical (OM) | United States | $0.043B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.020B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |